alexa Clinical Outcome In Patients With Cardiovascular Pathologies Treated With Clopigogrel: Impact Of Genotype Profile, Clopidogrel Metabolites PK And Comedication On The Clinical Results
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th World Congress on Bioavailability and Bioequivalence Pharmaceutical R&D Summit
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Luigi Silvestro
ScientificTracks Abstracts: J Bioequiv Availab
DOI: 10.4172/0975-0851.S1.017
Abstract
C lopidogrel presents a complex metabolism; in last years?, special attention was dedicated to identify genotypes resistant to treatment and FDA introduced a boxed warning in product leaflet for specific patient groups. Meanwhile it was observed that statins (some), proton pump inhibitors and other drugs interfere significantly with clopidogrel metabolism. In this study, patients (n=213) hospitalized for major cardiovascular problems (stable angina, ST elevation myocardial infarction, non-ST elevation myocardial infarctions) were given clopidogrel and followed clinically ≥2 years; patients received also other drugs (i.e., statins, antidiabetic, aspirin etc.) for concomitant pathologies and/or other invasive therapy (i.e., stenting) according to their lesion severity. All subjects were CYP2C19 genotyped (considered critical by FDA) and plasmatic levels of clopidogrel and 3 relevant metabolites (including the active-one) were determined at one time point to assess PK characteristics. Three groups of data were then obtained (clinical, genotype and PK) and correlations between them were statistically analyzed. Extremely interesting results have been obtained: 1) Genotype data actually poorly correlated with clinical data; 2) Clopidogrel PK seems unrelated to genotype while metabolites PK, especially of inactive-ones, correlate very well; 3) Concomitant therapies with several drugs have a highly relevant influence on clopidogrel metabolites PK (less with clopidogrel parent); 4) PK data of metabolites correlated very well with subjects survival. These data show the importance to carefully choose concomitant therapies when using clopidogrel, while genotype seems not to be as relevant as thought; the evaluation of clopidogrel metabolites PK is highly promising in clopidogrel therapy optimization
Biography
Luigi Silvestro graduated in Medicine in Turin (Italy) in 1984 and specialized in Pharmacology in 1988. From 1989 he is applying HPLC-MS in quantitation of bioanalytical samples as well as identification of drug metabolites. In 1996, he co-founded 3S-Pharmacological Consultation & Research GmbH, a consultation company and CRO, in Germany and is still actively involved in the development of innovative analytical methods. From 1998 the company has expanded the activity in East Europe (Romania, Moldavia) creating an analytical laboratory in Romania (Bucharest). In his scientific activity he has contributed to more than 50 articles in international scientific journals
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version